In vitrotreatment of monocytes with 8-methoxypsolaren and ultraviolet A light induces dendritic cells with a tolerogenic phenotype
Authors:
Open Access
- 15 March 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 148 (3) , 564-572
Abstract
Extracorporeal photopheresis (ECP) has been considered an efficient dendritic cell (DC) therapy, used for treating both T cell malignancy, as well as T cell-mediated diseases. During the ECP procedure leucocytes are exposed to photoactivable agent 8-methoxypsolaren (8-MOP) and ultraviolet (UV) A radiation (PUVA) prior to reinfusion. Despite its clinical efficacy the mechanism of action remains elusive. As it has been reported that ECP might promote the differentiation of monocytes into immature DCs, we investigated the effects of UVA light (2 J/cm2) and 8-MOP (100 ng/ml) on in vitro monocyte-to-DC differentiation from normal donors. DCs were generated from human purified CD14+ cells. Because monocytes are killed by PUVA and taking into account that only 5–10% of circulating mononuclear cells are exposed to PUVA during the ECP procedure, we developed an assay in which 10% of PUVA-treated monocytes were co-cultured with untreated monocytes. We first demonstrate that the presence of 10% apoptotic cells and monocyte activation were not enough to induce monocyte differentiation into DCs. Adding cytokines to our culture system, we obtained immature DCs characterized by significantly higher phagocytic activity and human leucocyte antigen D-related (HLA-DR) expression. These DCs preserved the capacity to be activated by lipopolysaccharide, but showed a reduced capacity to induce allogeneic T cell proliferation when first co-cultured with 10% of PUVA-treated cells. Our experimental design provides a novel insight into the real action of 8-MOP and UVA light on dendritic cell biology, suggesting an additional mechanism by which 8-MOP and UVA light exposure may influence immune responses.Keywords
This publication has 45 references indexed in Scilit:
- Impairment of Circulating Myeloid Dendritic Cells in Immunosuppressed Renal/Pancreas Transplant RecipientsTransplantation, 2006
- A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosisJournal of the American Academy of Dermatology, 2006
- Photopheresis versus transimmunization?Leukemia & Lymphoma, 2006
- Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft‐versus‐host diseaseTransfusion, 2005
- Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma GroupBritish Journal of Dermatology, 2005
- Photopheresis for the Treatment of Refractory Renal Graft RejectionTransplantation, 2005
- Extracorporeal Photopheresis Differentially Regulates the Expression or Phosphorylated STAT-1 and STAT-5 in Treated Monocytes and T Cells, RespectivelyJournal of Cutaneous Medicine and Surgery, 2004
- Dendritic CellsImmunity, 2004
- Extracorporeal Photopheresis for the Treatment of Cutaneous T-Cell LymphomaJournal of Cutaneous Medicine and Surgery, 2003
- Mechanisms of action of extracorporeal photochemotherapy in the control of GVHD: involvement of dendritic cellsLeukemia, 2003